Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Inmune Bio, Inc. (INMB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Bought 2,500 shares
@ $6.425, valued at
$16.1k
|
|
| 05/31/2022 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Bought 6,300 shares
@ $6.41, valued at
$40.4k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 23,590 shares
@ $8.43, valued at
$198.9k
Granted 104,000 options to buy
@ $7.92, valued at
$823.7k
|
|
| 03/23/2022 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 23,724 shares
@ $8.43, valued at
$200k
Granted 130,000 options to buy
@ $7.92, valued at
$1M
|
|
| 03/23/2022 |
4
| Schroeder Timothy j (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.92, valued at
$277.2k
|
|
| 03/23/2022 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 17,793 shares
@ $8.43, valued at
$150k
Granted 130,000 options to buy
@ $7.92, valued at
$1M
|
|
| 03/23/2022 |
4
| Juda Scott (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.92, valued at
$277.2k
|
|
| 03/23/2022 |
4
| Ganjei James Kelly (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 17,793 shares
@ $8.43, valued at
$150k
Granted 35,000 options to buy
@ $7.92, valued at
$277.2k
|
|
| 03/23/2022 |
4
| Baracchini Edgardo Jr (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.92, valued at
$277.2k
|
|
| 03/23/2022 |
4
| ALLEN MARCIA (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.92, valued at
$277.2k
|
|
| 11/17/2021 |
4
| Juda Scott (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Bought 2,500 shares
@ $13.55, valued at
$33.9k
|
|
| 11/04/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 701 shares
@ $20, valued at
$14k
|
|
| 11/04/2021 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 1,025 shares
@ $20, valued at
$20.5k
|
|
| 11/04/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 3,626 shares
@ $20, valued at
$72.5k
|
|
| 10/29/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 6,517 shares
@ $20, valued at
$130.3k
|
|
| 10/29/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 2,357 shares
@ $20, valued at
$47.1k
|
|
| 10/29/2021 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 2,079 shares
@ $20, valued at
$41.6k
|
|
| 10/26/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 23,616 shares
@ $20, valued at
$472.3k
|
|
| 10/26/2021 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 1,142 shares
@ $20, valued at
$22.8k
Sold 13 shares
@ $20, valued at
$260 |
|
| 10/26/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 400 shares
@ $20, valued at
$8k
|
|
| 09/08/2021 |
4/A
| Xencor Inc (10% Owner) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Acquired 192,533 shares
@ $17.14, valued at
$3.3M
|
|
| 09/08/2021 |
4/A
| Xencor Inc (10% Owner) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Acquired 192,533 shares
@ $17.14, valued at
$3.3M
|
|
| 09/08/2021 |
4
| Xencor Inc (10% Owner) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Exercised 108,000 options to buy
@ $7.8, valued at
$842.4k
|
|
| 08/27/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Exercised 30,000 options to buy
@ $3.91, valued at
$117.3k
|
|
| 07/19/2021 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Exercised 25,000 options to buy
@ $3.91, valued at
$97.8k
|
|
| 07/14/2021 |
4
| Schroeder Timothy j (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 14,480 shares
@ $27.63, valued at
$400.1k
|
|
| 07/12/2021 |
4
| Schroeder Timothy j (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 30,000 shares
@ $23.205, valued at
$696.2k
|
|
| 07/09/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 5,850 shares
@ $20.02, valued at
$117.1k
Sold 24,150 shares
@ $20.19, valued at
$487.6k
|
|
| 07/09/2021 |
4
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 8,698 shares
@ $20.0081, valued at
$174k
Sold 16,302 shares
@ $20.0891, valued at
$327.5k
|
|
| 07/09/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 5,649 shares
@ $20.018, valued at
$113.1k
Sold 24,351 shares
@ $20.08, valued at
$489k
|
|
| 06/24/2021 |
4
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 70,663 options
@ $17.49, valued at
$1.2M
|
|
| 06/24/2021 |
4
| Schroeder Timothy j (Director) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 19,025 options to buy
@ $17.49, valued at
$332.7k
|
|
|
|
|